NEW YORK (GenomeWeb News) - Bruker BioSciences shareholders overwhelmingly voted to approve the acquisition of molecular spectroscopy company Bruker Optics at today's annual meeting, the company said.
The $135 million deal, announced in April, would be paid approximately 59 percent in cash and 41 percent in the company's stock.
The board of directors of Bruker Optics and the independent directors on the board of directors for Bruker BioSciences previously approved the acquisition unanimously.